Investigation Into the Differentiation of Tumour and Healthy Brain Tissue Using Multi-exponential T2 Components
1 other identifier
observational
20
1 country
1
Brief Summary
The purpose of this study is to see if a specialized imaging technique using MRI called multi-exponential T2 component analysis can reliably differentiate between normal brain and brain tumour.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Feb 2009
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 19, 2008
CompletedFirst Posted
Study publicly available on registry
December 23, 2008
CompletedStudy Start
First participant enrolled
February 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2015
CompletedOctober 3, 2014
October 1, 2014
6.2 years
December 19, 2008
October 1, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
T2 characteristics of glioma tissue versus normal
Before radiotherapy treatment begins
Study Arms (2)
A. glioma
A. glioma population
B. Normal brain
B. Normal brain
Eligibility Criteria
A. Any glioma patient who recieves treatment at our clinic (Cross Cancer Institute) who agrees to take part in the study. B. Any normal volunteer who agrees to take part in the study.
You may qualify if:
- Eighteen years of age or older
- Clinical subjects must have not yet begun radiation therapy
- Must have signed our study-specific consent form
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cross Cancer Institute
Edmonton, Alberta, T6G 1Z2, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Keith Wachowicz, PhD
AHS Cancer Control Alberta
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 19, 2008
First Posted
December 23, 2008
Study Start
February 1, 2009
Primary Completion
April 1, 2015
Study Completion
April 1, 2015
Last Updated
October 3, 2014
Record last verified: 2014-10